Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

VAS-203 reduces ICP posttraumatic brain injury and improves neurological function

June 6, 2006

Neuroprotective effects of NNZ-2556 target delayed cell death

June 6, 2006

BG-00012 safe and reduces brain lesions in relapsing-remitting multiple sclerosis

June 6, 2006

Lyrica licensed in U.K. for GAD

June 1, 2006

Evidence that systemic application of XG-102 is neuroprotective postischemic stroke

June 1, 2006

New report from Prous Science reviews treatment options for patients with muscular dystrophy

May 31, 2006

Shire disappointed at NICE's recommendation on patients with mild Alzheimer's

May 31, 2006

Phase IIa trial studies Phosphagenics' transdermal morphine

May 31, 2006

Recent patents cover therapeutic agents for neurological disorders

May 30, 2006

Recent patents describe new analgesic agents

May 30, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.